,trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['breast', 'enhertu']
stunning results in breast cancer enhertu lowered risk of death / progression by 50% vs. chemo. my friend in the room at asco said there was a standing ovation and even tears at the presentation 
Healthcare/biotech. Assistant Professor Adjunct at @Yale | MPhil/PhD, @IIPP_UCL | Cofounder, @Azitrainc | Partner, Bios Partners | Forbes 30 | Opinions mine.